Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Investigator's Initiated Phase II Study for Pancreatic Cancer Patients

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified December 2013 by Tiltan Pharma Ltd.
Sponsor:
Information provided by (Responsible Party):
Tzivia Berkman, Tiltan Pharma Ltd.
ClinicalTrials.gov Identifier:
NCT01659502
First received: July 23, 2012
Last updated: December 4, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)